drugset / Trial / NCT02912169
Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer's Disease
NaSingle-groupOpen-labelTreatment
Summary
The intent of this clinical study is to answer the questions: 1) Is the proposed treatment safe and 2) Is treatment effective in improving the disease pathology of patients with Alzheimer's Disease and clinical outcomes?
Timeline
- Start
- 2015-11-01
- Primary completion
- 2017-11-15
- Completion
- 2017-11-15
Outcome
Outcome not reported
Stopped: “company dissolved”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AD-SVF | Cell therapy | — | Intravenous |